BOM:507747 (India)
Â
Shs Dematerialised
₹
1497.50
(+3.19%)
Nov 29
Business Description
TTK Healthcare Ltd
NAICS : 311919
ISIN : INE910C01018
Share Class Description:
BOM:507747: Shs DematerialisedCompare
Compare
Traded in other countries / regions
507747.India IPO Date
2001-02-20Description
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.21 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.26 | |||||
| Interest Coverage | 8.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.1 | |||||
| Beneish M-Score | -2.01 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.5 | |||||
| 3-Year EBITDA Growth Rate | 38 | |||||
| 3-Year EPS without NRI Growth Rate | 26.5 | |||||
| 3-Year Book Growth Rate | 50.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.61 | |||||
| 9-Day RSI | 52.2 | |||||
| 14-Day RSI | 47.97 | |||||
| 6-1 Month Momentum % | 2.64 | |||||
| 12-1 Month Momentum % | 13.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.17 | |||||
| Quick Ratio | 4.7 | |||||
| Cash Ratio | 4.2 | |||||
| Days Inventory | 99.94 | |||||
| Days Sales Outstanding | 43.61 | |||||
| Days Payable | 117.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.67 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 49.4 | |||||
| Forward Dividend Yield % | 0.67 | |||||
| 5-Year Yield-on-Cost % | 1.63 | |||||
| Shareholder Yield % | 0.66 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.63 | |||||
| Operating Margin % | 2.99 | |||||
| Net Margin % | 10.43 | |||||
| FCF Margin % | -2 | |||||
| ROE % | 7.96 | |||||
| ROA % | 6.57 | |||||
| ROIC % | 8.29 | |||||
| ROC (Joel Greenblatt) % | 106.26 | |||||
| ROCE % | 10.78 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.64 | |||||
| PE Ratio without NRI | 31.46 | |||||
| Shiller PE Ratio | 17.56 | |||||
| Price-to-Owner-Earnings | 37.91 | |||||
| PEG Ratio | 1.97 | |||||
| PS Ratio | 2.68 | |||||
| PB Ratio | 1.97 | |||||
| Price-to-Tangible-Book | 2.04 | |||||
| EV-to-EBIT | 11.09 | |||||
| EV-to-EBITDA | 10.12 | |||||
| EV-to-Revenue | 1.58 | |||||
| EV-to-FCF | -72.62 | |||||
| Price-to-Projected-FCF | 2.13 | |||||
| Price-to-Median-PS-Value | 1.85 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.3 | |||||
| Price-to-Graham-Number | 1.71 | |||||
| Price-to-Net-Current-Asset-Value | 2.27 | |||||
| Price-to-Net-Cash | 2.97 | |||||
| Earnings Yield (Greenblatt) % | 9.01 | |||||
| FCF Yield % | -0.73 | |||||
| Forward Rate of Return (Yacktman) % | 16.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TTK Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,661.381 | ||
| EPS (TTM) (₹) | 56.58 | ||
| Beta | 0.54 | ||
| Volatility % | 15.52 | ||
| 14-Day RSI | 47.97 | ||
| 14-Day ATR (₹) | 46.235239 | ||
| 20-Day SMA (₹) | 1491.92 | ||
| 12-1 Month Momentum % | 13.16 | ||
| 52-Week Range (₹) | 1232.05 - 1923 | ||
| Shares Outstanding (Mil) | 14.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TTK Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TTK Healthcare Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
TTK Healthcare Ltd Frequently Asked Questions
What is TTK Healthcare Ltd(BOM:507747)'s stock price today?
The current price of BOM:507747 is ₹1497.50. The 52 week high of BOM:507747 is ₹1923.00 and 52 week low is ₹1232.05.
When is next earnings date of TTK Healthcare Ltd(BOM:507747)?
The next earnings date of TTK Healthcare Ltd(BOM:507747) is .
Does TTK Healthcare Ltd(BOM:507747) pay dividends? If so, how much?
The Dividend Yield %  of TTK Healthcare Ltd(BOM:507747) is 0.67% (As of Today), Highest Dividend Payout Ratio of TTK Healthcare Ltd(BOM:507747) was 0.54. The lowest was 0.14. And the median was 0.25. The  Forward Dividend Yield % of TTK Healthcare Ltd(BOM:507747) is 0.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers